Table 3.
Polymer | Polymer-Accumulating Bacteria | Biomaterial Properties in Biomedical Application | Ref. |
---|---|---|---|
Polyhydroxyalkanoates | First isolated from Bacillus megaterium Multiple strains of Bacillus and Pseudomonas, including P. putida and B. aquamaris |
Several aspects have been considered, including wound healing patches by promoting angiogenesis in the healing process, bioresorbable sutures, and in drug delivery with a tailorable material degradation rate Useful in scaffold development for tissue engineering applications, which is biocompatible for a number of tissue types by facilitating cell seeding, adhesion, proliferation, differentiation, and de novo tissue regeneration. |
[248,249,250,251,252,253,254,255,256,257,258,259,260,261,262,263,264,265,266,267,268,269,270,271,272,273,274,275,276,277,278,279,280,281,282,283,284,285,286,287,288,289,290,291,292,293,294,295,296,297] |
Polylactic acid | PLA monomeric components being synthesized by bacteria of the order Lactobacillales Genetically modified Escherichia coli |
PLA is bioresorbable, allowing the material to naturally disintegrate as the target site is healing Acts as a scaffold for tissue engineering application and bone fixation purposes Prospective drug delivery material due to its tailorable porosity for controlled adsorption and drug release |
[298,299,300,301,302,303,304,305,306,307,308,309,310,311,312,313,314,315,316,317,318] |